Option Care Health (OPCH)
(Delayed Data from NSDQ)
$31.61 USD
+0.84 (2.73%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $31.59 -0.02 (-0.06%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OPCH 31.61 +0.84(2.73%)
Will OPCH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OPCH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPCH
OPCH vs. ASTH: Which Stock Is the Better Value Option?
Wall Street Analysts Predict a 31.8% Upside in Option Care (OPCH): Here's What You Should Know
OPCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Option Care Health (OPCH) Stock?
Option Care (OPCH) Q2 Earnings and Revenues Top Estimates
Chemed (CHE) Misses Q2 Earnings and Revenue Estimates
Other News for OPCH
Option Care Health Outperforms with Solid Growth and Upgraded Fiscal Outlook
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Qiagen (QGEN) and MiMedx Group (MDXG)
Option Care Health price target raised by $2 at Barrington, here's why
Option Care Health (OPCH) Gets a Buy from Truist Financial
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY), Teva Pharmaceutical (TEVA) and Option Care Health (OPCH)